These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 3179180
21. The effect of misonidazole in combination with radiation dose fractionation. Hill RP, Bush RS. Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242 [Abstract] [Full Text] [Related]
22. The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours. Fenton BM. Br J Cancer; 1995 May; 71(5):945-9. PubMed ID: 7734318 [Abstract] [Full Text] [Related]
23. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours. Durand RE, Chaplin DJ. Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461 [Abstract] [Full Text] [Related]
24. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069. Hill RP, Gulyas S, Whitmore GF. Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053 [Abstract] [Full Text] [Related]
25. The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours. Masunaga S, Ono K, Abe M. Br J Radiol; 1993 Oct; 66(790):918-26. PubMed ID: 8220977 [Abstract] [Full Text] [Related]
26. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT, Siemann DW. Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329 [Abstract] [Full Text] [Related]
27. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations. Grdina DJ, Sigdestad CP, Jovonovich JA. Cancer Clin Trials; 1980 Oct; 3(2):149-54. PubMed ID: 7428138 [Abstract] [Full Text] [Related]
28. Are direct measures of tumor oxygenation reflective of changes in tumor radiosensitivity following oxygen manipulation? Fenton BM, Siemann DW. Acta Oncol; 1995 Oct; 34(3):307-11. PubMed ID: 7779414 [Abstract] [Full Text] [Related]
32. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU. Mulcahy RT, Siemann DW, Sutherland RM. Br J Cancer; 1981 Jan; 43(1):93-9. PubMed ID: 7459244 [Abstract] [Full Text] [Related]
33. Is tumour radiosensitization by misonidazole a general phenomenon? Denekamp J, Hirst DG, Stewart FA, Terry NH. Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769 [Abstract] [Full Text] [Related]
34. The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects. Yamagata M, Tannock IF. Br J Cancer; 1996 Jun; 73(11):1328-34. PubMed ID: 8645575 [Abstract] [Full Text] [Related]
35. Radiobiological hypoxia in the KHT sarcoma: predictions using the Eppendorf histograph. Siemann DW, Johansen IM, Horsman MR. Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1171-6. PubMed ID: 9539574 [Abstract] [Full Text] [Related]
37. Combined modality therapy with bleomycin, hyperthermia, and radiation. Teicher BA, Herman TS, Holden SA. Cancer Res; 1988 Nov 15; 48(22):6291-7. PubMed ID: 2460220 [Abstract] [Full Text] [Related]
38. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Urano M, Kuroda M, Reynolds R, Oberley TD, St Clair DK. Cancer Res; 1995 Jun 15; 55(12):2490-3. PubMed ID: 7780953 [Abstract] [Full Text] [Related]
39. Interaction of hyperthermia and radiation in murine cells: hypoxia and acidosis in vitro, tumor subpopulations in vivo. Herman TS, Teicher BA, Holden SA, Collins LS. Cancer Res; 1989 Jun 15; 49(12):3338-43. PubMed ID: 2720686 [Abstract] [Full Text] [Related]
40. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors. Ding I, Huang K, Snyder ML, Cook J, Zhang L, Wersto N, Okunieff P. J Natl Cancer Inst; 1996 Oct 02; 88(19):1399-404. PubMed ID: 8827018 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]